Potential mechanisms of leukemia cell resistance to TRAIL-induced apopotosis
Authors:
- 1 December 2003
- journal article
- Published by Springer Nature in Apoptosis
- Vol. 8 (6) , 601-607
Abstract
There are many factors contributing to the resistance to TRAIL (Tumor necrosis factor-related apoptosis-inducing ligand)-induced apoptosis. However, it is not clear whether the mechanism of resistance to TRAIL is constitutive or inductive. Therefore, the purpose of this study was to investigate the resistant mechanisms to TRAIL at different levels in the apoptotic pathway. The human T-lymphoblastic leukemic CEM cell line showed more resistant to TRAIL-induced apoptosis compared with the human chronic myeloid leukemic K562 cell line. Lower level of constitutive caspase-8 expression in the CEM cell line led to a poor response to both TRAIL-induced activation of caspase-3 and reduction in the mitochondrial membrane potential (ΔΨm). There was no significant difference in the constitutive levels of NF-κB in CEM and K562 cell lines. However, CEM cells showed a faster response to TRAIL-induced NF-κB activation than K562 cells. TRAIL-induced regulation of Bcl-2 family of proteins included an up-regulation in Bcl-2/Bcl-XL and a down-regulation in Bax. IAPs, such as XIAP, cIAP-1, cIAP-2 and Survivin were all up-regulated during the treatment with TRAIL. In summary, our data suggest that the leukemic cells resistance to TRAIL-induced apoptosis might be due to the deficiency in the constitutive caspase-8 expression. Development of potential resistance to apoptosis by TRAIL can occur in both TRAIL-resistant and TRAIL-sensitive leukemic cells.Keywords
This publication has 26 references indexed in Scilit:
- α-Tocopheryl succinate sensitises a T lymphoma cell line to TRAIL-induced apoptosis by suppressing NF-κB activationBritish Journal of Cancer, 2003
- Triptolide sensitizes lung cancer cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by inhibition of NF-κB activationExperimental & Molecular Medicine, 2002
- Defining Characteristics of Types I and II Apoptotic Cells in Response to TRAILNeoplasia, 2002
- TRAIL-Induced Apoptosis in Type I Leukemic Cells Is Not Enhanced by Overexpression of BaxBiochemical and Biophysical Research Communications, 2001
- Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosisOncogene, 2000
- Resistance to TRAIL-induced apoptosis in primitive neuroectodermal brain tumor cells correlates with a loss of caspase-8 expressionOncogene, 2000
- Smac, a Mitochondrial Protein that Promotes Cytochrome c–Dependent Caspase Activation by Eliminating IAP InhibitionCell, 2000
- TRAIL Causes Cleavage of Bid by Caspase-8 and Loss of Mitochondrial Membrane Potential Resulting in Apoptosis in BJAB CellsBiochemical and Biophysical Research Communications, 1999
- TRAIL: a molecule with multiple receptors and control mechanismsCurrent Opinion in Immunology, 1998
- Bid, a Bcl2 Interacting Protein, Mediates Cytochrome c Release from Mitochondria in Response to Activation of Cell Surface Death ReceptorsCell, 1998